All that's happening in generics and biosimilars
Generics bulletin provides its subscribers with up-to-date commercial intelligence about business opportunities in the global generic medicines and biosimilars markets.
Accurate and reliable news reports reveal the strategies of the world’s leading generics companies and analyse their business performance, plans and product portfolios.
Patent and pricing issues, regulatory changes, government initiatives, market opportunities and industry consolidation provide the wider context for Generics bulletin’s comprehensive industry coverage.
With subscribers in nearly 60 countries, Generics bulletin is read by senior executives in all of the world’s leading generics companies, as well as by industry watchers and those supplying active ingredients, goods and services to the global generic medicines industry.
An annual subscription comprises:
- 20 Generics bulletin newsletters;
- AND at least 46 weekly News@Genericsbulletin electronic newsflashes containing the week’s top news stories (currently delivered by email).
Choice of formats
The 20 Generics bulletin newsletters are available:
- EITHER as the digital Generics bulletin-i for online access by desktop AND tablet and smartphone. These mobile devices can have Apple or Android operating systems;
- OR in traditional hard-copy print format, delivered by airmail.
The digital edition Generics bulletin-i has two significant benefits – it is available on the day of publication with no postal delay; and it contains a fully word-searchable archive containing over 100 Generics bulletin editions dating back to 2008.
Subscribers may subscribe to either or both formats.
Discounts are available for Generics bulletin-i multi-user subscriptions for colleagues at the same location. Click the subscribe tab above for subscription rates.
For details of our special rates for multiple subscriptions at more than one location contact subscriptions@Generics-bulletin.com
A corporate subscription provides location-, country- or company-wide access to Generics bulletin-i. Contact subscriptions@Generics-bulletin.com for further details.